Evidence map›Paper›PMID 24349525›Full record

ArticlePloS one2013

Effects of resveratrol on the recovery of muscle mass following disuse in the plantaris muscle of aged rats.

Brian T Bennett, Junaith S Mohamed, Stephen E Alway

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 114 citations in OpenAlex.

  1. Trial
  2. Resveratrol Enhances Exercise-Induced Cellular and Functional Adaptations of Skeletal Muscle in Older Men and Women.The journals of gerontology. Series A, Biological sciences and medical sciences · 2017
    Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Sarcopenia in chronic kidney disease: from bench to bedside.The Korean journal of internal medicine · 2023
    Review
  18. Article
  19. Review
  20. Review

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Brian T BennettLaboratory of Muscle Biology and Sarcopenia Division of Exercise Physiology, West Virginia University School of Medicine, Morgantown, West Virginia, United States of America ; West Virginia Center for Clinical and Translational Science Institute, Morgantown, West Virginia, United States of America.
Junaith S MohamedLaboratory of Muscle Biology and Sarcopenia Division of Exercise Physiology, West Virginia University School of Medicine, Morgantown, West Virginia, United States of America ; West Virginia Center for Clinical and Translational Science Institute, Morgantown, West Virginia, United States of America.
Stephen E AlwayLaboratory of Muscle Biology and Sarcopenia Division of Exercise Physiology, West Virginia University School of Medicine, Morgantown, West Virginia, United States of America ; West Virginia Center for Clinical and Translational Science Institute, Morgantown, West Virginia, United States of America ; Center for Cardiovascular, and Respiratory Sciences, West Virginia University School of Medicine, Morgantown, West Virginia, United States of America.
West Virginia University · US

Funding

West Virginia IDEA-CTRU54GM104942 · NIGMS · WEST VIRGINIA UNIVERSITY · PI Laura F. Gibson · 2012 to 2026
$81.0M
THE ROLE OF HEF1 PROTEIN IN INVASION OF METASTATIC BREAST CANCERP20RR016440 · NCRR · WEST VIRGINIA UNIVERSITY · PI CUFF, CHRISTOPHER F · 2001 to 2010
$22.8M
West Virginia Flow Cytometry Core FacilityP30GM103488 · NIGMS · WEST VIRGINIA UNIVERSITY · PI CUFF, CHRISTOPHER F · 2012 to 2016
$4.8M
NCRR NIH HHS 5P20RR016440-09NCRR NIH HHS P20 RR016440NIGMS NIH HHS P30 GM103488NIGMS NIH HHS U54 GM104942NIGMS NIH HHS U54GM104942
6 · The paper itself

Abstract

Aging is associated with poor skeletal muscle regenerative ability following extended periods of hospitalization and other forms of muscular disuse. Resveratrol (3,5,4'-trihydroxystilbene) is a natural phytoalexin which has been shown in skeletal muscle to improve oxidative stress levels in muscles of aged rats. As muscle disuse and reloading after disuse increases oxidative stress, we hypothesized that resveratrol supplementation would improve muscle regeneration after disuse. A total of thirty-six male Fisher 344 × Brown Norway rats (32 mo.) were treated with either a water vehicle or resveratrol via oral gavage. The animals received hindlimb suspension for 14 days. Thereafter, they were either sacrificed or allowed an additional 14 day period of cage ambulation during reloading. A total of six rats from the vehicle and the resveratrol treated groups were used for the hindlimb suspension and recovery protocols. Furthermore, two groups of 6 vehicle treated animals maintained normal ambulation throughout the experiment, and were used as control animals for the hindlimb suspension and reloading groups. The data show that resveratrol supplementation was unable to attenuate the decreases in plantaris muscle wet weight during hindlimb suspension but it improved muscle mass during reloading after hindlimb suspension. Although resveratrol did not prevent fiber atrophy during the period of disuse, it increased the fiber cross sectional area of type IIA and IIB fibers in response to reloading after hindlimb suspension. There was a modest enhancement of myogenic precursor cell proliferation in resveratrol-treated muscles after reloading, but this failed to reach statistical significance. The resveratrol-associated improvement in type II fiber size and muscle mass recovery after disuse may have been due to decreases in the abundance of pro-apoptotic proteins Bax, cleaved caspase 3 and cleaved caspase 9 in reloaded muscles. Resveratrol appears to have modest therapeutic benefits for improving muscle mass after disuse in aging.

Indexed as

AnimalsAnti-Inflammatory Agents, Non-Steroidalbcl-2-Associated X ProteinCaspase 3MaleMuscle ProteinsMuscle, SkeletalMuscular AtrophyOrgan SizeRatsRats, Inbred F344ResveratrolStilbenesAnti-Inflammatory Agents, Non-SteroidalBax protein, ratbcl-2-Associated X ProteinCasp3 protein, ratCaspase 3Muscle ProteinsResveratrolStilbenes

Identifiers

PMID24349525
PMCPMC3861503
OpenAlexW2045762097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.